{
    "summary": "Only limited material is available in the selected language. All content is\navailable on the global site.\n\nClose\n\n##### Wolters Kluwer Navigation\n\nAbout Wolters Kluwer\n\n  * Solutions Directory\n  * Careers\n  * Investors\n  * Select Language\n\nAbout Wolters Kluwer\n\nWolters Kluwer is a global provider of professional information, software\nsolutions, and services for clinicians, nurses, accountants, lawyers, and tax,\nfinance, audit, risk, compliance, and regulatory sectors.\n\n######  About Us\n\n  * About Wolters Kluwer\n  * Strategy\n  * Our Organization\n  * Management\n  * Supervisory Board\n  * Value Creation\n  * Events\n\n######  Expert Insights\n\n  * All Expert Insights\n  * Health\n  * Tax & Accounting\n  * ESG\n  * Finance\n  * Compliance\n  * Legal\n\n######  Get Help\n\n  * Contact Us\n  * Login\n  * View Solution List\n  * eShop & Bookstores\n  * Media Center\n  * News & Press Releases\n\n  * Solutions Directory\n  * Careers\n  * Investors\n  * Select Language\n\nPrimaryNav Button\n\nSearch Wolters Kluwer\n\n/Feature/WoltersKluwer/OneWeb/SearchHeader/Search\n/Feature/WoltersKluwer/OneWeb/SearchHeader/Search\n\nNo Suggestion\n\nExpand Search\n\nVisit our global site in English, or select an alternative location or\nlanguage below\n\n  * Americas \n\n  * Europe \n\n  * Asia & Pacific \n\n###### Brazil\n\nHome page:\n\n  * Portuguese\n\n###### Canada\n\nHome page:\n\n  * English\n\n  * French\n\n###### Latin America\n\nHome page:\n\n  * Spanish\n\n###### United States\n\nHome page:\n\n  * English\n\nCurrent Page:\n\n  * English\n\n###### Belgium\n\nHome page:\n\n  * Dutch\n\n  * French\n\n###### Czech Republic\n\nHome page:\n\n  * Czech\n\n###### Denmark\n\nHome page:\n\n  * Denmark\n\n###### France\n\nHome page:\n\n  * French\n\n###### Germany\n\nHome page:\n\n  * German\n\n###### Hungary\n\nHome page:\n\n  * Hungarian\n\n###### Italy\n\nHome page:\n\n  * Italian\n\n###### Netherlands\n\nHome page:\n\n  * Dutch\n\n###### Norway\n\nHome page:\n\n  * Norwegian\n\n###### Poland\n\nHome page:\n\n  * Polish\n\n###### Portugal\n\nHome page:\n\n  * Portuguese\n\n###### Romania\n\nHome page:\n\n  * Romanian\n\n###### Slovakia\n\nHome page:\n\n  * Slovak\n\n###### Spain\n\nHome page:\n\n  * Spanish\n\n###### Sweden\n\nHome page:\n\n  * Swedish\n\n###### United Kingdom\n\nHome page:\n\n  * English\n\n###### Australia\n\nHome page:\n\n  * English\n\n###### China\n\nHome page:\n\n  * Simplified Chinese\n\n###### Hong Kong\n\nHome page:\n\n  * English\n\n###### India\n\nHome page:\n\n  * English\n\n###### Japan\n\nHome page:\n\n  * Japanese\n\n###### Malaysia\n\nHome page:\n\n  * English\n\n###### New Zealand\n\nHome page:\n\n  * English\n\n###### Philippines\n\nHome page:\n\n  * English\n\n###### Singapore\n\nHome page:\n\n  * English\n\n###### South Korea\n\nHome page:\n\n  * English\n\n###### Taiwan\n\nHome page:\n\n  * English\n\n###### Thailand\n\nHome page:\n\n  * English\n\n###### Vietnam\n\nHome page:\n\n  * English\n\n##### Primary Navigation\n\n  * Health\n\nHealth\n\nTrusted clinical technology and evidence-based solutions that drive effective\ndecision-making and outcomes across healthcare. Specialized in clinical\neffectiveness, learning, research and safety.\n\nHealth Overview\n\n###### Solutions\n\n    * UpToDateIndustry-leading clinical decision support\n    * OvidThe world\u2019s most trusted medical research platform\n    * LexicompEvidence-based drug referential solutions\n    * Sentri7 Clinical SurveillanceTargeting infection prevention, pharmacy and sepsis management\nView All Solutions\n\n###### Challenges\n\n    * Optimizing Clinical Workflows\n    * Improving Patient Safety\n    * Leveraging Clinical Decision Support\n    * Reducing Clinical Variation\nView All Challenges\n\n###### Expert Insights\n\n    * Deciphering medical jargon: How payers can help members bridge the information gap\n    * Drug decision-making: Why alignment between PBMs, payers, and other stakeholders matters\n    * Using evidence-based guidelines to improve prescribing\n    * Using evidence-based strategies to help reduce malpractice risk\nView All Expert Insights\n\n  * Tax & Accounting\n\nTax & Accounting\n\nEnabling tax and accounting professionals and businesses of all sizes drive\nproductivity, navigate change, and deliver better outcomes. With workflows\noptimized by technology and guided by deep domain expertise, we help\norganizations grow, manage, and protect their businesses and their client\u2019s\nbusinesses.\n\nTax & Accounting Overview\n\n###### Solutions\n\n    * Tax & Accounting U.S. HubCentral hub for all U.S. solutions\n    * CCH Axcess\u2122 SuiteCloud-based tax preparation and compliance, workflow management and audit solution\n    * CCH\u00ae ProSystem fx\u00aeIntegrated tax, accounting and audit, and workflow software tools\n    * TaxWise\u00aeTax Preparation Software for Tax Preparers\nView All Solutions\n\n###### Trending Topics\n\n    * Beneficial Ownership Information\n    * Corporate Transparency Act \n\n###### Expert Insights\n\n    * The Tax Relief for American Families and Workers Act of 2024\n    * 4 stages to efficiency with fund and financial accounting automation \n    * CCH Axcess\u2122 tips and tricks for the best tax season support\n    * GASB issues guidance on disclosure of certain risks\nView All Expert Insights\n\n  * ESG\n\nESG\n\nOffering comprehensive tools and expert guidance to companies to help meet\nregulatory requirements to support sustainability efforts and manage ESG risks\nefficiently.\n\nESG Overview\n\n###### Solutions\n\n    * CCH TagetikUnified performance management software\n    * OneSumXDiscover our solution for ESG climate risk and regulatory requirements \n    * TeamMateSolutions for auditors\n    * EnablonSoftware solutions for risk & compliance, engineering & operations, and EHSQ & sustainability\nView All Solutions\n\n###### Expert Insights\n\n    * ESG: Results matter more than the letters\n    * The increasing importance of global green tax initiatives\n    * How to improve corporate sustainability communications\n    * Utilizing data analytics to help support ESG reporting\n    * Corporate Social Responsibility (CSR) and Environmental, Social, and Governance (ESG) \n    * On-demand webinar: ESG - Going green and reporting it!\n    * Verdantix Green Quadrant: PSM Software 2023\n    * Emerging trends in Financial Consolidation: Non-Financial Data, AI and ESG Metrics\nView All Expert Insights\n\n  * Finance\n\nFinance\n\nOur solutions for regulated financial departments and institutions help\ncustomers meet their obligations to external regulators. We specialize in\nunifying and optimizing processes to deliver a real-time and accurate view of\nyour financial position.\n\nFinance Overview\n\n###### Solutions\n\n    * CCH TagetikUnified performance management software\n    * OneSumX for Finance, Risk and Regulatory ReportingIntegrated regulatory compliance and reporting solution suite \n    * Lien SolutionsMarket leader in UCC filing, searches, and management\n    * eOriginaleOriginal securely digitizes the lending process from the close to the secondary market\nView All Solutions\n\n###### Expert Insights\n\n    * Beyond Financials: The xP&A revolution in Planning\n    * Why every EPM tool needs an ownership structure register\n    * 4 stages to efficiency with fund and financial accounting automation \n    * The disruption continuum: A Q4 2023 automotive survey of the industry\u2019s journey from paper to digital\n    * Manage projects unique to Tax with CCH Axcess\u2122 Workflow\n    * Case Study: The building blocks of financial transformation in 2024\n    * Tutorial: How to produce the right products at the right time\n    * Budgeting Software: BPM Buyers Guide for Budgeting & Planning\nView All Expert Insights\n\n  * Compliance\n\nCompliance\n\nEnabling organizations to ensure adherence with ever-changing regulatory\nobligations, manage risk, increase efficiency, and produce better business\noutcomes.\n\nCompliance Overview\n\n###### Solutions\n\n    * OneSumX for Finance, Risk and Regulatory ReportingIntegrated regulatory compliance and reporting solution suite\n    * BizFilings Incorporation services for entrepreneurs\n    * EnablonSoftware solutions for risk & compliance, engineering & operations, and EHSQ & sustainability\n    * CT CorporationRegistered agent & business license solutions\nView All Solutions\n\n###### Trending Topics\n\n    * Beneficial Ownership Information\n    * Corporate Transparency Act \n    * Economic and interest rate forecasts\n\n###### Expert Insights\n\n    * Technology and digital closing solutions are top priorities for the mortgage industry in 2024\n    * How to get a business license\n    * FinCEN issues new FAQs on the beneficial ownership reporting\n    * Large insurance company gains efficiencies with TeamMate+ Data Exchange API\nView All Expert Insights\n\n  * Legal\n\nLegal\n\nServing legal professionals in law firms, General Counsel offices and\ncorporate legal departments with data-driven decision-making tools. We\nstreamline legal and regulatory research, analysis, and workflows to drive\nvalue to organizations, ensuring more transparent, just and safe societies.\n\nLegal Overview\n\n###### Solutions\n\n    * Kluwer ArbitrationOnline resource for international arbitration research\n    * Enterprise Legal ManagementLegal spend and matter management, AI legal bill review, and analytics solutions\n    * LegiswayAll-in-one legal management software for legal departments\n    * VitalLaw\u00aeLegal research database for attorneys\nView All Solutions\n\n###### Trending Topics\n\n    * Beneficial Ownership Information\n    * Corporate Transparency Act \n    * Economic and interest rate forecasts\n\n###### Expert Insights\n\n    * Infographic: Seamless scalability. Unlimited potential.\n    * Kluwer Arbitration User Forum 5\n    * The importance of human-centered AI\n    * Case study: Commit to compliance to control legal spend at the source\nView All Expert Insights\n\n  1. Back to  Home  >\n  2. Back to  Expert Insights  >\n  3. Drug manufacturing licensing requirements\n\nComplianceSeptember 07, 2023\n\n# Drug manufacturing licensing requirements\n\nBy: Hans Howk\n\nThe United States is a world leader in drug discovery and development. But, in\nrecent years, drug manufacturing has increasingly moved offshore to countries\nlike India and China.\n\nTo reverse the offshore trend and revitalize American manufacturing, the U.S.\nDepartment of Health and Human Services (HHS) plans to establish a DPA Title\nIII Protection to provide financial aid to build and expand the health\nresources industrial base.\n\nIf you\u2019re a drug manufacturer or thinking of starting this type of business,\nyou will be subject to federal and state government licensing laws. These laws\nalso extend to anyone who distributes, dispenses, and sells prescription drugs\nand devices.\n\nTo ensure you are compliant, here is an overview of the registration process\nand drug manufacturer licensing requirements in the United States.\n\nDrug manufacturing licensing requirements\n\nLearn the business license state requirements for drug manufacturing\n\nAccess the Smart Chart\n\n## Federal requirements\n\nIf you own or operate a drug or pharmaceutical manufacturing establishment,\nyou are required to register it with the Food and Drug Administration (FDA) at\nleast five days after starting operations. According to the FDA, a drug\nmanufacturer is anyone who is engaged in manufacturing, preparing,\npropagating, compounding, processing, packaging, repackaging, or labeling of a\nprescription drug.\n\nAs part of the registration process, you must list each drug manufactured by\nyour company that is intended for commercial distribution and submit this\ninformation to the FDA twice a year, in June and December, and notify the\nagency if any information has changed.\n\nRegistration renewal occurs between October 1 and December 31 each year.\nHowever, listing updates can occur at any time during the year.\n\nIf your business involves controlled substances, you are subject to additional\nrequirements. For example, if you distribute, store, or manufacture a named\ncontrolled substance, you must apply for a federal controlled substances\nregistration issued by the Drug Enforcement Agency (DEA). A separate DEA\nregistration is also required for each place of business or practice at a\nphysical location where controlled substances are manufactured. This\nregistration is subject to annual renewal.\n\n## State requirements for business licenses\n\nA drug manufacturing license is required at the state level. These laws and\nlicense types vary from state to state. For example, depending on your state,\nyou may need a manufacturer license, wholesale distributor license, or\npharmacy facility license.\n\nIf you deal with controlled substances, separate state licensing and permit\nrequirements exist.\n\nWhen applying for a drug manufacturer license, you must provide the following\ninformation:\n\n  * Proof of FDA drug establishment registration\n  * Corporate documents\n  * Certificate of Good Standing\n  * Proof of registered agent\n  * Facility plans or construction drawings\n  * Description of security system and security measures in place\n  * Facility manager information\n  * Self-inspection report\n  * List of drugs to be manufactured/repackaged\n  * Copy of VAWD certificate\n  * Lease/zoning statement\n  * Certificate of insurance\n\nBefore a license is issued, the state could also require a facility\ninspection.\n\n## State licensing requirements for virtual manufacturers\n\nMany states now require licensure of virtual manufacturers. A virtual drug\nmanufacturer sells its own prescription drugs, products, and/or devices but\noutsources the manufacturing and distribution process. (I.e., they never take\npossession of the product.)\n\nMany states include virtual manufacturers in the same compliance bucket as\nwholesalers. These licensing requirements can be very specialized, and you may\nchoose to request certain exemptions.\n\n## Licensing requirements for change of ownership\n\nIf your business undergoes a change of ownership, depending on the state in\nwhich you operate, you may be required to notify the appropriate pharmacy\nboard of the change.\n\nTo continue operations, some states also require an application for a new\nlicense. If the application is received within a certain timeframe, the\nfacility can typically continue operating until the new license is issued.\n\nHowever, there are exceptions, and some states do not allow continued\noperations after closure of the original business or change of ownership if\nthe application is pending.\n\nBecause these laws are complex and vary, it\u2019s best to consult a legal services\nprovider who can identify the actions your company must take in accordance\nwith regulations and guide you through the process.\n\n## Do cosmetic manufacturers need a drug manufacturing license?\n\nCertain cosmetic products meet the definition of both cosmetics and drugs.\nThis generally happens when a product has two intended purposes. For example,\nan anti-dandruff shampoo is considered a drug since it\u2019s a dermatological\ntreatment. This is also the case with toothpaste, deodorants that contain\nantiperspirants, moisturizers and makeup advertised with sun protection\nclaims. Such products must comply with licensing requirements for drugs and\ncosmetics.\n\n## CT Corporation can help\n\nCT Corporation can help you stay up to date with changing requirements and\nforms so you can focus on running a successful drug or pharmaceutical\nmanufacturing business. We complete license applications efficiently and\ncorrectly, so you don\u2019t spend time chasing down the proper licenses. Once your\ndrug manufacturing license has been issued, we ensure that you remain\ncompliant will all licensing laws.\n\nTo learn more about how CT Corporation can help you manage your business\nlicense needs, contact a CT Corporation Service Representative or call (844)\n878-1800.\n\n#### Please complete the form below for access to the smart chart:\n\n#### Missing the form below?\n\nTo see the form, you will need to change your cookie settings. Click the\nbutton below to update your preferences to accept all cookies. For more\ninformation, please review our Privacy & Cookie Notice.\n\nManage Cookie Preferences\n\nHans Howk\n\nManager, Content Management\n\nHans provides internal support to key members of the Business Licensing Team,\nassisting with understanding industry nuances, searching and synthesizing\nstatutes and regulations relating to business law.\n\nExplore related topics\n\nEffective decision makingBusiness Licenses\n\nBusiness license managed services\n\nCT Corporation manages the lifecycle of all your business licenses and\nprovides ongoing support for your core business license program.\n\n\n\nManaged Services Details\n\nExpert Insights\n\nStay informed\n\nSubscribe to CT Corporation's newsletters for business compliance updates and\nlegislative news.\n\nSign up\n\nAdditional information\n\nContact CT Corporation\n\nAccess resources\n\nView events\n\nContact CT Corporation\n\nContact us today for business registration and business compliance assistance.  \n\nContact a Specialist\n\n#### Related insights\n\nHow to get a business license Grocery store business license requirements\nBusiness license requirements for food processing and manufacturing\n\n## Related Insights\n\n  * Article \n\nCompliance\n\nJanuary 17, 2024\n\nHow to get a business license\n\nWhatever your business type, you\u2019ll need to obtain the right business licenses\nor permits. Read more in \"How to get a business license\".\n\nLearn More\n\n  * Article \n\nCompliance\n\nJanuary 17, 2024\n\nFinCEN issues new FAQs on the beneficial ownership reporting\n\nThe Financial Crimes Enforcement Network issued 10 new FAQs, providing\nadditional guidance and information related to the BOI reporting requirement.\n\nLearn More\n\n  * Article \n\nCompliance\n\nJanuary 16, 2024\n\nGrocery store business license requirements\n\nCheck out this article where we break down the essential business license\nrequirements at the federal, state, and local levels for a grocery store\nbusiness.\n\nLearn More\n\n  * Article \n\nCompliance\n\nJanuary 16, 2024\n\nBusiness license requirements for food processing and manufacturing\n\nDiscover the business licenses you need, and the dos and don\u2019ts when managing\na food processing and manufacturing operation.\n\nLearn More\n\n##### Footer Navigation\n\n  * About Wolters Kluwer\n\n  * Strategy\n\n  * Our Organization\n\n  * Management\n\n  * Supervisory Board\n\n  * Value Creation\n\n  * News & Press Releases\n\n  * Events\n\n  * Solutions Directory\n\n  * Health\n\n  * Tax & Accounting\n\n  * ESG\n\n  * Finance\n\n  * Compliance\n\n  * Legal\n\n  * Expert Insights\n\n  * Careers\n\n  * Investors\n\n  * Sitemap\n\n  * Site Owner\n\n### CT Corporation\n\n  * Contact CT\n\n  * Login Your Account\n\n  * Create Account\n\n  * Pay an Invoice\n\n  * Update Email Subscriptions\n\n  * Access W-9 Form\n\n###### Follow Wolters Kluwer\n\n  * Facebook\n\n  * Twitter\n\n  * LinkedIn\n\n  * YouTube\n\n###### Follow CT Corporation\n\n  * Facebook\n\n  * Twitter\n\n  * LinkedIn\n\n  * YouTube\n\nWhen you have to be right\n\n  * Terms of Use\n\n  * Privacy & Cookies\n\n  * Your California Privacy Choices\n\n### CT Corporation\n\n  * CT Corporation service descriptions\n\n  * CT Corporation disclaimer\n\n  * CT Corporation terms and conditions\n\n\u00a9 2024 Wolters Kluwer N.V. and/or its subsidiaries. All rights reserved.\n\nBack To Top\n\n",
    "links": "[{\"link\": \"https://www.wolterskluwer.com/en\", \"text\": \"All content is available on the global site.\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions\", \"text\": \"Solutions Directory\"}, {\"link\": \"https://www.wolterskluwer.com/en/investors\", \"text\": \"Investors\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us\", \"text\": \"About Wolters Kluwer\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/strategy\", \"text\": \"Strategy\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/organization\", \"text\": \"Our Organization\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/management\", \"text\": \"Management\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/supervisory-board\", \"text\": \"Supervisory Board\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/value-creation\", \"text\": \"Value Creation\"}, {\"link\": \"https://www.wolterskluwer.com/en/events\", \"text\": \"Events\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights\", \"text\": \"All Expert Insights\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/health\", \"text\": \"Health\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/tax-and-accounting\", \"text\": \"Tax & Accounting\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/esg\", \"text\": \"ESG\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/finance\", \"text\": \"Finance\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/compliance\", \"text\": \"Compliance\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/legal\", \"text\": \"Legal\"}, {\"link\": \"https://www.wolterskluwer.com/en/contact-us\", \"text\": \"Contact Us\"}, {\"link\": \"https://www.wolterskluwer.com/en/my-account-login\", \"text\": \"Login\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions\", \"text\": \"View Solution List\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/bookstores\", \"text\": \"eShop & Bookstores\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/corporate-media-center\", \"text\": \"Media Center\"}, {\"link\": \"https://www.wolterskluwer.com/en/news\", \"text\": \"News & Press Releases\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions\", \"text\": \"Solutions Directory\"}, {\"link\": \"https://www.wolterskluwer.com/en/investors\", \"text\": \"Investors\"}, {\"link\": \"https://www.wolterskluwer.com/en\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/pt-br\", \"text\": \"Portuguese\"}, {\"link\": \"https://www.wolterskluwer.com/en-ca\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/fr-ca\", \"text\": \"French\"}, {\"link\": \"https://www.wolterskluwer.com/es\", \"text\": \"Spanish\"}, {\"link\": \"https://www.wolterskluwer.com/en\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/drug-manufacturing-licensing-requirements\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/nl-be\", \"text\": \"Dutch\"}, {\"link\": \"https://www.wolterskluwer.com/fr-be\", \"text\": \"French\"}, {\"link\": \"https://www.wolterskluwer.com/cs-cz\", \"text\": \"Czech\"}, {\"link\": \"https://www.wolterskluwer.com/da-dk\", \"text\": \"Denmark\"}, {\"link\": \"https://www.wolterskluwer.com/fr-fr\", \"text\": \"French\"}, {\"link\": \"https://www.wolterskluwer.com/de-de\", \"text\": \"German\"}, {\"link\": \"https://www.wolterskluwer.com/hu-hu\", \"text\": \"Hungarian\"}, {\"link\": \"https://www.wolterskluwer.com/it-it\", \"text\": \"Italian\"}, {\"link\": \"https://www.wolterskluwer.com/nl-nl\", \"text\": \"Dutch\"}, {\"link\": \"https://www.wolterskluwer.com/nb-no\", \"text\": \"Norwegian\"}, {\"link\": \"https://www.wolterskluwer.com/pl-pl\", \"text\": \"Polish\"}, {\"link\": \"https://www.wolterskluwer.com/pt-pt\", \"text\": \"Portuguese\"}, {\"link\": \"https://www.wolterskluwer.com/ro-ro\", \"text\": \"Romanian\"}, {\"link\": \"https://www.wolterskluwer.com/sk-sk\", \"text\": \"Slovak\"}, {\"link\": \"https://www.wolterskluwer.com/es-es\", \"text\": \"Spanish\"}, {\"link\": \"https://www.wolterskluwer.com/sv-se\", \"text\": \"Swedish\"}, {\"link\": \"https://www.wolterskluwer.com/en-gb\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en-au\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/zh-cn\", \"text\": \"Simplified Chinese\"}, {\"link\": \"https://www.wolterskluwer.com/en-hk\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en-in\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/ja-jp\", \"text\": \"Japanese\"}, {\"link\": \"https://www.wolterskluwer.com/en-my\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en-nz\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en-ph\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en-sg\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/ko-kr\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/zh-tw\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/th-th\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/vi-vn\", \"text\": \"English\"}, {\"link\": \"https://www.wolterskluwer.com/en/health\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/uptodate\", \"text\": \"UpToDate\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ovid\", \"text\": \"Ovid\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/lexicomp\", \"text\": \"Lexicomp\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/sentri7-clinical-surveillance\", \"text\": \"Sentri7 Clinical Surveillance\"}, {\"link\": \"https://www.wolterskluwer.com/en/health/our-solutions\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/healthcare-challenges/optimizing-clinical-workflows\", \"text\": \"Optimizing Clinical Workflows\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/healthcare-challenges/improving-patient-safety\", \"text\": \"Improving Patient Safety\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/healthcare-challenges/clinical-decision-support\", \"text\": \"Leveraging Clinical Decision Support\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/healthcare-challenges/reducing-clinical-variation\", \"text\": \"Reducing Clinical Variation\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/healthcare-challenges\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/deciphering-med-jargon-payers-help-members-bridge-decision-making-info-gap\", \"text\": \"Deciphering medical jargon: How payers can help members bridge the information gap\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/drug-decision-making-alignment-between-pbms-payers-stakeholders-matters\", \"text\": \"Drug decision-making: Why alignment between PBMs, payers, and other stakeholders matters\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/using-evidence-based-guidelines-to-improve-prescribing\", \"text\": \"Using evidence-based guidelines to improve prescribing\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/using-evidence-based-strategies-to-help-reduce-malpractice-risk\", \"text\": \"Using evidence-based strategies to help reduce malpractice risk\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/health\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/tax-and-accounting\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/tax-accounting-us\", \"text\": \"Tax & Accounting U.S. Hub\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/cch-axcess\", \"text\": \"CCH Axcess\u2122 Suite\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/cch-prosystem-fx\", \"text\": \"CCH\u00ae ProSystem fx\u00ae\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/taxwise\", \"text\": \"TaxWise\u00ae\"}, {\"link\": \"https://www.wolterskluwer.com/en/tax-and-accounting/our-solutions\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/beneficial-ownership-information-reporting\", \"text\": \"Beneficial Ownership Information\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/beneficial-ownership-information-reporting\", \"text\": \"Corporate Transparency Act \"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/tax-relief-for-american-families-and-workers-act-of-2024\", \"text\": \"The Tax Relief for American Families and Workers Act of 2024\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/wb-4-stages-efficiency-with-financial-accounting-automation\", \"text\": \"4 stages to efficiency with fund and financial accounting automation \"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/cch-axcess-tips-and-tricks-for-the-best-tax-season-support\", \"text\": \"CCH Axcess\u2122 tips and tricks for the best tax season support\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/gasb-issues-guidance-on-disclosure-of-certain-risks\", \"text\": \"GASB issues guidance on disclosure of certain risks\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/tax-and-accounting\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/esg\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/cch-tagetik/esg-sustainability-performance-management\", \"text\": \"CCH Tagetik\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/onesumx-for-finance-risk-and-regulatory-reporting/onesumx-for-esg\", \"text\": \"OneSumX\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/teammate/esg\", \"text\": \"TeamMate\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/enablon\", \"text\": \"Enablon\"}, {\"link\": \"https://www.wolterskluwer.com/en/esg/our-solutions\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/esg-results-matter-more-than-the-letters\", \"text\": \"ESG: Results matter more than the letters\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/increasing-importance-of-global-green-tax-initiatives\", \"text\": \"The increasing importance of global green tax initiatives\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/how-to-improve-corporate-sustainability-communications\", \"text\": \"How to improve corporate sustainability communications\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/utilizing-data-analytics-to-help-support-esg-reporting\", \"text\": \"Utilizing data analytics to help support ESG reporting\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/corporate-social-responsibility-csr-environmental-social-governance-esg\", \"text\": \"Corporate Social Responsibility (CSR) and Environmental, Social, and Governance (ESG) \"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/esg-going-green-and-reporting-it\", \"text\": \"On-demand webinar: ESG - Going green and reporting it!\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/verdantix-green-quadrant-psm-software-2023\", \"text\": \"Verdantix Green Quadrant: PSM Software 2023\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/emerging-trends-in-financial-consolidation\", \"text\": \"Emerging trends in Financial Consolidation: Non-Financial Data, AI and ESG Metrics\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/esg?f:interestarea=ESG\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/finance\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/cch-tagetik\", \"text\": \"CCH Tagetik\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/onesumx-for-finance-risk-and-regulatory-reporting\", \"text\": \"OneSumX for Finance, Risk and Regulatory Reporting\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/lien-solutions\", \"text\": \"Lien Solutions\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/eoriginal\", \"text\": \"eOriginal\"}, {\"link\": \"https://www.wolterskluwer.com/en/finance/our-solutions\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/wb-xpa-revolution-in-planning-beyond-financials\", \"text\": \"Beyond Financials: The xP&A revolution in Planning\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/wb-why-epm-tool-needs-ownership-structure-register\", \"text\": \"Why every EPM tool needs an ownership structure register\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/wb-4-stages-efficiency-with-financial-accounting-automation\", \"text\": \"4 stages to efficiency with fund and financial accounting automation \"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/a-survey-of-automotive-industrys-journey-from-paper-to-digital\", \"text\": \"The disruption continuum: A Q4 2023 automotive survey of the industry\u2019s journey from paper to digital\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/wb-manage-projects-to-tax-cch-axcess-workflow\", \"text\": \"Manage projects unique to Tax with CCH Axcess\u2122 Workflow\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/wb-case-study-building-blocks-financial-transformation\", \"text\": \"Case Study: The building blocks of financial transformation in 2024\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/tutorial-wb-how-produce-rights-products-right-time\", \"text\": \"Tutorial: How to produce the right products at the right time\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/bpm-bpf-solutions\", \"text\": \"Budgeting Software: BPM Buyers Guide for Budgeting & Planning\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/finance\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/compliance\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/onesumx-for-finance-risk-and-regulatory-reporting\", \"text\": \"OneSumX for Finance, Risk and Regulatory Reporting\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/bizfilings\", \"text\": \"BizFilings \"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/enablon\", \"text\": \"Enablon\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation\", \"text\": \"CT Corporation\"}, {\"link\": \"https://www.wolterskluwer.com/en/compliance/our-solutions\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/beneficial-ownership-information-reporting\", \"text\": \"Beneficial Ownership Information\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/beneficial-ownership-information-reporting\", \"text\": \"Corporate Transparency Act \"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/us-economy-forecast-blue-chip-economic-indicators-outlook-for-the-year-ahead\", \"text\": \"Economic and interest rate forecasts\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/technology-and-digital-closing-solutions-are-top-priorities-for-the-mortgage-industry-in-2024\", \"text\": \"Technology and digital closing solutions are top priorities for the mortgage industry in 2024\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/how-to-get-a-business-license\", \"text\": \"How to get a business license\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/fincen-issues-new-faqs-on-the-beneficial-ownership-reporting\", \"text\": \"FinCEN issues new FAQs on the beneficial ownership reporting\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/large-insurance-company-efficiencies-with-teammate-data-exchange-api\", \"text\": \"Large insurance company gains efficiencies with TeamMate+ Data Exchange API\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/compliance\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/legal\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/kluwerarbitration\", \"text\": \"Kluwer Arbitration\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/enterprise-legal-management\", \"text\": \"Enterprise Legal Management\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/legisway\", \"text\": \"Legisway\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/vitallaw-law-firms\", \"text\": \"VitalLaw\u00ae\"}, {\"link\": \"https://www.wolterskluwer.com/en/legal/our-solutions\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/beneficial-ownership-information-reporting\", \"text\": \"Beneficial Ownership Information\"}, {\"link\": \"https://www.wolterskluwer.com/en/know/beneficial-ownership-information-reporting\", \"text\": \"Corporate Transparency Act \"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/us-economy-forecast-blue-chip-economic-indicators-outlook-for-the-year-ahead\", \"text\": \"Economic and interest rate forecasts\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/infographic-seamless-scalability-unlimited-potential\", \"text\": \"Infographic: Seamless scalability. Unlimited potential.\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/kluwer-arbitration-user-forum-5\", \"text\": \"Kluwer Arbitration User Forum 5\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/the-importance-of-human-centered-ai\", \"text\": \"The importance of human-centered AI\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/case-study-commit-compliance-control-legal-spend-at-source\", \"text\": \"Case study: Commit to compliance to control legal spend at the source\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/legal\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/experts/hans-howk\", \"text\": \"Hans Howk\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/durable-medical-equipment-licensing-requirements\", \"text\": \"devices\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/controlled-substance-registration-requirements\", \"text\": \"controlled substances\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/certificate-good-standing-and-certificate-existence\", \"text\": \"Certificate of Good Standing\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/registered-agent-services-solutions\", \"text\": \" registered agent\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/business-license-solutions\", \"text\": \"business license needs\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/contact-llx\", \"text\": \"CT Corporation Service Representative\"}, {\"link\": \"https://www.wolterskluwer.com/en/experts/hans-howk\", \"text\": \"Hans Howk\"}, {\"link\": \"https://www.wolterskluwer.com/en/search-results/topic/effective-decision-making\", \"text\": \"Effective decision making\"}, {\"link\": \"https://www.wolterskluwer.com/en/search-results/topic/business-licenses\", \"text\": \"Business Licenses\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/business-license-managed-services\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/resources/ct-request-email-update\", \"text\": \"Sign up\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/contact\", \"text\": \"Contact CT Corporation\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/search-results?f:contenttype=Insight%20Article%20Page%7CInsight%20Case%20Study%20Page%7CInsight%20Event%20Page%7CInsight%20Infographic%20Page%7CInsight%20Podcast%20%20Page%7CInsight%20Video%20Page&f:solutionsuite=CT%20Corporation&sortBy=editorialpublishdate_dt%7CDescending\", \"text\": \"Access resources\"}, {\"link\": \"https://www.wolterskluwer.com/en/events?f:solutionsuite=CT%20Corporation\", \"text\": \"View events\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/contact\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/how-to-get-a-business-license\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/grocery-store-business-license-requirements\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/business-license-requirements-for-food-processing-and-manufacturing\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/how-to-get-a-business-license\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/fincen-issues-new-faqs-on-the-beneficial-ownership-reporting\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/grocery-store-business-license-requirements\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights/business-license-requirements-for-food-processing-and-manufacturing\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us\", \"text\": \"About Wolters Kluwer\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/strategy\", \"text\": \"Strategy\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/organization\", \"text\": \"Our Organization\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/management\", \"text\": \"Management\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/supervisory-board\", \"text\": \"Supervisory Board\"}, {\"link\": \"https://www.wolterskluwer.com/en/about-us/value-creation\", \"text\": \"Value Creation\"}, {\"link\": \"https://www.wolterskluwer.com/en/news\", \"text\": \"News & Press Releases\"}, {\"link\": \"https://www.wolterskluwer.com/en/events\", \"text\": \"Events\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions\", \"text\": \"Solutions Directory\"}, {\"link\": \"https://www.wolterskluwer.com/en/health\", \"text\": \"Health\"}, {\"link\": \"https://www.wolterskluwer.com/en/tax-and-accounting\", \"text\": \"Tax & Accounting\"}, {\"link\": \"https://www.wolterskluwer.com/en/esg\", \"text\": \"ESG\"}, {\"link\": \"https://www.wolterskluwer.com/en/finance\", \"text\": \"Finance\"}, {\"link\": \"https://www.wolterskluwer.com/en/compliance\", \"text\": \"Compliance\"}, {\"link\": \"https://www.wolterskluwer.com/en/legal\", \"text\": \"Legal\"}, {\"link\": \"https://www.wolterskluwer.com/en/expert-insights\", \"text\": \"Expert Insights\"}, {\"link\": \"https://www.wolterskluwer.com/en/investors\", \"text\": \"Investors\"}, {\"link\": \"https://www.wolterskluwer.com/en/sitemap\", \"text\": \"Sitemap\"}, {\"link\": \"https://www.wolterskluwer.com/en/site-owner\", \"text\": \"Site Owner\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/contact\", \"text\": \"Contact CT\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/resources/login-ct-corporation\", \"text\": \"Login Your Account\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/resources/ct-request-email-update\", \"text\": \"Update Email Subscriptions\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/ct-w-9-form\", \"text\": \"Access W-9 Form\"}, {\"link\": \"https://www.wolterskluwer.com/en\", \"text\": \"\"}, {\"link\": \"https://www.wolterskluwer.com/en/terms-of-use\", \"text\": \"Terms of Use\"}, {\"link\": \"https://www.wolterskluwer.com/en/privacy-cookies\", \"text\": \"Privacy & Cookies\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/resources/service-descriptions\", \"text\": \"CT Corporation service descriptions\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/resources/disclaimer\", \"text\": \"CT Corporation disclaimer\"}, {\"link\": \"https://www.wolterskluwer.com/en/solutions/ct-corporation/resources/services-terms-and-conditions\", \"text\": \"CT Corporation terms and conditions\"}]"
}